COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

被引：0
作者：
Teich, V [1 ]
Passos, R. B. F. [1 ]
Vianna, D. [2 ]
机构：
[1] MedInsight, Rio De Janeiro, Brazil
[2] Univ Rio de Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75381-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [31] Budgetary impact analysis of alteplase-recombinant tissue plasminogen activator (rtPA)-as a thrombolytic treatment for acute ischemic stroke in Colombia
    Gil-Rojas, Yaneth
    Lasalvia, Pieralessandro
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (07) : 1095 - 1102
  • [32] Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
    Joo, Heesoo
    Wang, Guijing
    George, Mary G.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (06) : S205 - S212
  • [33] Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI
    Schellinger, PD
    Jansen, O
    Fiebach, JB
    Heiland, S
    Steiner, T
    Schwab, SF
    Pohlers, O
    Ryssel, H
    Sartor, K
    Hacke, W
    STROKE, 2000, 31 (06) : 1318 - 1328
  • [34] COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY FOR ACUTE ISCHEMIC STROKE: COLOMBIAN HEALTH SYSTEM PERSPECTIVE
    Caicedo, Giraldo A.
    Ruiz, A. J.
    Holguin, D. J., I
    Rojas, Escobar W.
    Rosselli, D.
    VALUE IN HEALTH, 2023, 26 (06) : S79 - S79
  • [35] Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke in Patients with Metabolic Syndrome
    Sobolewski, Piotr
    Brola, Waldemar
    Szczuchniak, Wiktor
    Fudala, Magorzata
    Kozera, Grzegorz
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08) : 1787 - 1792
  • [36] The Effect Of Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator (rt-PA) For Acute Ischemic Stroke
    Pan Shuming
    Shen Sa
    Dai Lihua
    Li Haojun
    Liu Ming
    STROKE, 2011, 42 (03) : E126 - E126
  • [37] Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in Acute Ischemic Stroke due to Middle Cerebral Artery Dissection
    Doijiri, Ryosuke
    Yokota, Chiaki
    Suzuki, Rieko
    Toyoda, Kazunori
    Minematsu, Kazuo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08) : 915.e7 - 915.e9
  • [38] Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
    Ehlers, Lars
    Andersen, Grethe
    Clausen, Lone Beltoft
    Bech, Merete
    Kjolby, Mette
    STROKE, 2007, 38 (01) : 85 - 89
  • [39] Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
    Demaerschalk, BM
    Silver, B
    Merino, JG
    Wong, E
    Hill, MD
    Poncha, F
    Foell, B
    Tamayo, A
    Buchan, AM
    Hachinski, V
    STROKE, 2003, 34 (01) : 248 - 249
  • [40] Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients on Aspirin and Clopidogrel
    Qureshi, Mushtaq H.
    Khan, Shayaan M.
    Jahangir, Nauman
    Malik, Ahmed A.
    Freese, Melissa
    Thompson, Michelle
    Khan, Asif A.
    Suri, M. Fareed K.
    Qureshi, Adnan I.
    STROKE, 2015, 46
12345